Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells

Experimental Cell Research

Volumn 316, Issue 3, 2010, Pages 433-442

  García Becerra, Rocío ^a   Díaz, Lorenza ^a   Camacho, Javier ^b   Barrera, David ^a   Ordaz Rosado, David ^a   Morales, Angélica ^a   Ortiz, Cindy Sharon ^a   Avila, Euclides ^a   Bargallo, Enrique ^c   Arrecillas, Myrna ^c   Halhali, Ali ^a   Larrea, Fernando ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Astemizole; Breast cancer; K+ channels; TEI 9647; VDR; Vitamin D

Indexed keywords

ASTEMIZOLE; CALCITRIOL; POTASSIUM CHANNEL HERG; VITAMIN D RECEPTOR;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST FIBROADENOMA; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 72149105032     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.11.008     Document Type: Article

References (39)

1. Dusso A.S., Brown A.J., Slatopolsky E., and Vitamin D. Am. J. Physiol. Renal. Physiol. 289 (2005) F8-F28
2. Kemmis C.M., Salvador S.M., Smith K.M., and Welsh J. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. J. Nutr. 136 (2006) 887-892
3. Zinser G.M., Welsh J., and Vitamin D. receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis 25 (2004) 2361-2372
4. Zinser G.M., and Welsh J. Effect of Vitamin D3 receptor ablation on murine mammary gland development and tumorigenesis. J. Steroid Biochem. Mol. Biol. 89-90 (2004) 433-436
5. Welsh J. Vitamin D and prevention of breast cancer. Acta. Pharmacol. Sin. 28 (2007) 1373-1382
6. Deeb K.K., Trump D.L., and Johnson C.S. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer. 7 (2007) 684-700
7. Knight J.A., Lesosky M., Barnett H., Raboud J.M., and Vieth R. Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 422-429
8. Welsh J. Vitamin D and breast cancer: insights from animal models. Am. J. Clin. Nutr. 80 (2004) 1721S-1724S
9. Fleet J.C. Molecular actions of vitamin D contributing to cancer prevention. Mol. Aspects Med. 29 (2008) 388-396
10. Beer T.M., and Myrthue A. Calcitriol in cancer treatment: from the lab to the clinic. Mol. Cancer Ther. 3 (2004) 373-381
11. Lowe L., Hansen C.M., Senaratne S., and Colston K.W. Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent Results Cancer Res. 164 (2003) 99-110
12. Flanagan L., Packman K., Juba B., O'Neill S., Tenniswood M., and Welsh J. Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion. J. Steroid. Biochem. Mol. Biol. 84 (2003) 181-192
13. Camacho J. Ether a go-go potassium channels and cancer. Cancer Lett. 233 (2006) 1-9
14. Downie B.R., Sanchez A., Knotgen H., Contreras-Jurado C., Gymnopoulos M., Weber C., Stuhmer W., and Pardo L.A. Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. J. Biol. Chem. (2008)
15. Ben-Shoshan M., Amir S., Dang D.T., Dang L.H., Weisman Y., and Mabjeesh N.J. 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol. Cancer Ther. 6 (2007) 1433-1439
16. Pardo L.A., and Stuhmer W. Eag1 as a cancer target. Expert Opin. Ther. Targets 12 (2008) 837-843
17. Pardo L.A., del Camino D., Sanchez A., Alves F., Bruggemann A., Beckh S., and Stuhmer W. Oncogenic potential of EAG K(+) channels. EMBO J. 18 (1999) 5540-5547
18. Hemmerlein B., Weseloh R.M., Mello de Queiroz F., Knotgen H., Sanchez A., Rubio M.E., Martin S., Schliephacke T., Jenke M., Heinz Joachim R., Stuhmer W., and Pardo L.A. Overexpression of Eag1 potassium channels in clinical tumours. Mol. Cancer 5 (2006) 41
19. Burdall S.E., Hanby A.M., Lansdown M.R., and Speirs V. Breast cancer cell lines: friend or foe?. Breast Cancer Res. 5 (2003) 89-95
20. Li Z., Bustos V., Miner J., Paulo E., Meng Z.H., Zlotnikov G., Ljung B.M., and Dairkee S.H. Propagation of genetically altered tumor cells derived from fine-needle aspirates of primary breast carcinoma. Cancer Res. 58 (1998) 5271-5274
21. Veneziani B.M., Criniti V., Cavaliere C., Corvigno S., Nardone A., Picarelli S., Tortora G., Ciardiello F., Limite G., and De Placido S. In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches. Mol. Cancer Ther. 6 (2007) 3091-3100
22. Peng X., Jhaveri P., Hussain-Hakimjee E.A., and Mehta R.G. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5. Carcinogenesis 28 (2007) 1000-1007
23. Ouadid-Ahidouch H., and Ahidouch A. K+ channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis. J. Membr. Biol. 221 (2008) 1-6
24. Colston K.W., and Hansen C.M. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr. Relat. Cancer 9 (2002) 45-59
25. Weber C., Mello de Queiroz F., Downie B.R., Suckow A., Stuhmer W., and Pardo L.A. Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference. J. Biol. Chem. 281 (2006) 13030-13037
26. Ouadid-Ahidouch H., Le Bourhis X., Roudbaraki M., Toillon R.A., Delcourt P., and Prevarskaya N. Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channel. Receptors Channels 7 (2001) 345-356
27. Welsh J., Wietzke J.A., Zinser G.M., Smyczek S., Romu S., Tribble E., Welsh J.C., Byrne B., and Narvaez C.J. Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J. Steroid Biochem. Mol. Biol. 83 (2002) 85-92
28. Sher E., Eisman J.A., Moseley J.M., and Martin T.J. Whole-cell uptake and nuclear localization of 1,25-dihydroxycholecalciferol by breast cancer cells (T47 D) in culture. Biochem. J. 200 (1981) 315-320
29. Deng C., Ueda E., Chen K.E., Bula C., Norman A.W., Luben R.A., and Walker A.M. Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells. Mol. Endocrinol. 23 (2009) 226-236
30. Diaz L., Ceja-Ochoa I., Restrepo-Angulo I., Larrea F., Avila-Chavez E., Garcia-Becerra R., Borja-Cacho E., Barrera D., Ahumada E., Gariglio P., Alvarez-Rios E., Ocadiz-Delgado R., Garcia-Villa E., Hernandez-Gallegos E., Camacho-Arroyo I., Morales A., Ordaz-Rosado D., Garcia-Latorre E., Escamilla J., Sanchez-Pena L.C., Saqui-Salces M., Gamboa-Dominguez A., Vera E., Uribe-Ramirez M., Murbartian J., Ortiz C.S., Rivera-Guevara C., De Vizcaya-Ruiz A., and Camacho J. Estrogens and human papilloma virus oncogenes regulate human ether-a-go-go-1 potassium channel expression. Cancer Res. 69 (2009) 3300-3307
31. Sun X.X., Bostrom S.L., and Griffith L.C. Alternative splicing of the eag potassium channel gene in Drosophila generates a novel signal transduction scaffolding protein. Mol. Cell. Neurosci. 40 (2009) 338-343
32. Bauer C.K., and Schwarz J.R. Physiology of EAG K+ channels. J. Membr. Biol. 182 (2001) 1-15
33. Crews S.T., and Fan C.M. Remembrance of things PAS: regulation of development by bHLH-PAS proteins. Curr. Opin. Genet. Dev. 9 (1999) 580-587
34. Welsh J., Wietzke J.A., Zinser G.M., Byrne B., Smith K., and Narvaez C.J. Vitamin D-3 receptor as a target for breast cancer prevention. J. Nutr. 133 (2003) 2425S-2433S
35. Sarrio D., Rodriguez-Pinilla S.M., Hardisson D., Cano A., Moreno-Bueno G., and Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 68 (2008) 989-997
36. Livasy C.A., Karaca G., Nanda R., Tretiakova M.S., Olopade O.I., Moore D.T., and Perou C.M. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod. Pathol. 19 (2006) 264-271
37. Stark A., Hulka B.S., Joens S., Novotny D., Thor A.D., Wold L.E., Schell M.J., Melton L.J., 3rd E.T., and Liu K. Conway, HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer. J. Clin. Oncol. 18 (2000) 267-274
38. Gaugris S., Heaney R.P., Boonen S., Kurth H., Bentkover J.D., and Sen S.S. Vitamin D inadequacy among post-menopausal women: a systematic review. QJM 98 (2005) 667-676
39. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin. Proc. 81 (2006) 353-373